Surgery Partners, Inc. has announced a definitive agreement under which HealthSpan Partners will acquire the company in an all-cash transaction valued at approximately $5.7 billion. This acquisition is significant for Surgery Partners, as it aims to enhance its growth potential and strengthen its position in the healthcare market.
The acquisition reflects a trend in the services-general medical and surgical hospitals sector, where companies are increasingly seeking to expand their operational capabilities and geographic reach. Surgery Partners operates more than 200 locations across 30 states and has approximately 5,000 affiliated physicians, making it an attractive target for HealthSpan Partners.
Background
Surgery Partners, Inc. is a leading provider in the healthcare sector, classified under the SIC code 8062, which encompasses services related to general medical and surgical hospitals. The company trades on the Nasdaq under the ticker symbol SGRY. Recently, Surgery Partners filed several forms with the SEC, including a 10-Q and multiple DEFA14A submissions, indicating ongoing corporate activity and strategic planning.
What the Filing Says
According to the filing, Surgery Partners stated, "We are excited about the path forward and confident that this transaction will create lasting benefits for our patients, physicians, and shareholders." This sentiment highlights the company's optimism regarding the acquisition and its potential impact on its operations.
Impact
The acquisition is expected to affect various stakeholders, including Surgery Partners' shareholders, employees, and the healthcare community at large. With HealthSpan Partners as the new investor, Surgery Partners aims to expand access to high-quality care and enhance the patient experience.
What's Next
The transaction is expected to close in the first quarter of 2027, pending the approval of Surgery Partners' shareholders, regulatory approvals, and the satisfaction of other customary closing conditions. As the process moves forward, Surgery Partners has committed to keeping stakeholders informed about developments.
For more information, the filing can be accessed through the SEC's website under accession number 0001104659-26-124583.
Read Next
Quantum Space Updates on Lunar Missions, Satellite Technology
Werewolf Therapeutics announces merger with Ambros Therapeutics
NEXROC Group files tender offer for Capri Holdings Limited
Meyer Gregory S. Seeks Board Seat at Vail Resorts Amid Decline
Braze Files Preliminary Proxy for Salesforce Acquisition
First Financial Corp announces merger with First Illinois Corp










